Photo courtesy of Google Maps

Beacon Capital Partners’ newest local acquisition is a four-building Wellesley office campus with potential for a life science conversion.

The Boston-based real estate investor acquired the 375,058-square-foot Park 9 campus from Sun Life for $202 million.

Along with office buildings leased to Sun Life, Morgan Stanley and Boston Children’s Hospital, the property includes a 120,000-square-foot building that’s suitable for an immediate lab conversion, according to brokerage Newmark which represented the sellers.

The transaction includes properties at 96, 100, 110 and 112 Worcester St.

“Park 9 offers the exact type of self-contained, amenity-rich, mixed-use campus environment that appeals to life science users. The park further benefits from a highly-visible, strategic location in the southwest quadrant of suburban Boston’s key Route 128/Route 9 interchange,” Newmark Executive Vice Chairman Edward Maher said in a statement. Newmark represented the seller and procured the buyer.

In January, Beacon Capital submitted an application to the Wellesley planning board for a lab conversion at its 93 Worcester St. property, located across the street from the Park 9 campus. That project would convert half of the east wing, or 40,000 square feet, into lab-ready space.